Calendar

pharmadog

Week of Mar 30, 2026

Mar 31, 2026approval151d agoDEPAKOTE (DIVALPROEX SODIUM) — FDA approvaldivalproex sodium DR

Sponsor: ABBVIE. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL

full page →divalproex sodium DR →fda approvals ↗

Mar 31, 2026approval151d agoSTAVZOR (VALPROIC ACID) — FDA approvalVALPROIC ACID

Sponsor: BIONPHARMA. Form: CAPSULE, DELAYED RELEASE. Route: ORAL

full page →VALPROIC ACID →fda approvals ↗

Mar 31, 2026approval151d agoVALPROATE SODIUM — FDA approvalSagent Pharmaceuticals Inc

Sponsor: HIKMA FARMACEUTICA. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Mar 31, 2026approval151d agoVALPROATE SODIUM — FDA approvalSagent Pharmaceuticals Inc

Sponsor: HIKMA FARMACEUTICA. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Mar 31, 2026approval151d agoVALPROATE SODIUM — FDA approvalSagent Pharmaceuticals Inc

Sponsor: HIKMA FARMACEUTICA. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Mar 31, 2026approval151d agoVALPROIC ACID — FDA approvalVALPROIC ACID

Sponsor: LANNETT CO INC. Form: SYRUP. Route: ORAL

full page →VALPROIC ACID →fda approvals ↗

Mar 31, 2026approval151d agoMETHYLENE BLUE — FDA approvalMETHYLENE BLUE

Sponsor: ZYDUS LIFESCIENCES. Form: SOLUTION. Route: INTRAVENOUS

full page →METHYLENE BLUE →fda approvals ↗

Mar 31, 2026approval151d agoDEPAKOTE ER (DIVALPROEX SODIUM) — FDA approvaldivalproex sodium DR

Sponsor: ABBVIE. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →divalproex sodium DR →fda approvals ↗

Mar 31, 2026approval151d agoDEPAKOTE (DIVALPROEX SODIUM) — FDA approvaldivalproex sodium DR

Sponsor: ABBVIE. Form: TABLET, DELAYED RELEASE. Route: ORAL

full page →divalproex sodium DR →fda approvals ↗

Mar 31, 2026approval151d agoVALPROATE SODIUM — FDA approvalVALPROATE SODIUM

Sponsor: FRESENIUS KABI USA. Form: INJECTABLE. Route: INJECTION

full page →VALPROATE SODIUM →fda approvals ↗

Mar 31, 2026approval151d agoVALPROATE SODIUM — FDA approvalVALPROATE SODIUM

Sponsor: SAGENT. Form: INJECTABLE. Route: INJECTION

full page →VALPROATE SODIUM →fda approvals ↗

Mar 31, 2026approval151d agoVALPROIC ACID — FDA approvalVALPROIC ACID

Sponsor: HIKMA. Form: SYRUP. Route: ORAL

full page →VALPROIC ACID →fda approvals ↗

Mar 31, 2026approval151d agoVALPROIC ACID — FDA approvalCereno Scientific AB

Sponsor: HIBROW HLTHCARE. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Mar 31, 2026approval151d agoVALPROIC ACID — FDA approvalCereno Scientific AB

Sponsor: PHARMOBEDIENT CNSLTG. Form: SYRUP. Route: ORAL

full page →fda approvals ↗

Mar 31, 2026approval151d agoVALPROIC ACID — FDA approvalANI PHARMACEUTICALS INC

Sponsor: ANI PHARMS. Form: SYRUP. Route: ORAL

full page →fda approvals ↗

Mar 31, 2026approval151d agoINBRIJA (LEVODOPA) — FDA approvallevodopa

Sponsor: MERZ. Form: POWDER. Route: INHALATION

full page →levodopa →fda approvals ↗

Mar 31, 2026approval151d agoOLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalSciegen Pharmaceuticals Inc

Sponsor: SCIEGEN PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Mar 31, 2026approval151d agoVALPROATE SODIUM — FDA approvalSagent Pharmaceuticals Inc

Sponsor: PHARMOBEDIENT. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Mar 31, 2026approval151d agoVALPROIC ACID — FDA approvalCereno Scientific AB

Sponsor: CHARTWELL RX. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Mar 31, 2026approval151d agoVALPROIC ACID — FDA approvalCereno Scientific AB

Sponsor: CHARTWELL RX. Form: SYRUP. Route: ORAL

full page →fda approvals ↗

Mar 31, 2026approval151d agoMESALAMINE — FDA approvalTakeda Pharmaceuticals USA Inc

Sponsor: KLM LABS PVT. Form: ENEMA. Route: RECTAL

full page →fda approvals ↗

Apr 1, 2026approval150d agoLIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approvaladrenaline

Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

full page →adrenaline →fda approvals ↗

Apr 1, 2026approval150d agoLAMOTRIGINE — FDA approvalTorrent Pharma Inc

Sponsor: TARO PHARM INDS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Apr 1, 2026approval150d agoLAMOTRIGINE — FDA approvalTorrent Pharma Inc

Sponsor: TARO PHARM INDS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Apr 1, 2026approval150d agoBOSENTAN — FDA approvalJanssen-Cilag Holdings Inc (Inactive)

Sponsor: SUN PHARM. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Apr 1, 2026approval150d agoBOSENTAN — FDA approvalJanssen-Cilag Holdings Inc (Inactive)

Sponsor: SUN PHARM. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Apr 1, 2026approval150d agoBOSENTAN — FDA approvalJanssen-Cilag Holdings Inc (Inactive)

Sponsor: SUN PHARM. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Apr 1, 2026approval150d agoLIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approvaladrenaline

Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

full page →adrenaline →fda approvals ↗

Apr 1, 2026approval150d agoVAFSEO (VADADUSTAT) — FDA approvalvadadustat

Sponsor: AKEBIA. Form: TABLET. Route: ORAL

full page →vadadustat →fda approvals ↗

Apr 1, 2026approval150d agoKESIMPTA (OFATUMUMAB) — FDA approvalKESIMPTA

Sponsor: NOVARTIS. Form: SOLUTION. Route: SUBCUTANEOUS

full page →KESIMPTA →fda approvals ↗

Apr 1, 2026approval150d agoLIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approvaladrenaline

Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

full page →adrenaline →fda approvals ↗

Apr 1, 2026approval150d agoLIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approvaladrenaline

Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

full page →adrenaline →fda approvals ↗

Apr 1, 2026approval150d agoLIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approvaladrenaline

Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

full page →adrenaline →fda approvals ↗

Apr 1, 2026approval150d agoLIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approvaladrenaline

Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

full page →adrenaline →fda approvals ↗

Apr 1, 2026approval150d agoBREXPIPRAZOLE — FDA approvalBREXPIPRAZOLE

Sponsor: AMNEAL. Form: TABLET. Route: ORAL

full page →BREXPIPRAZOLE →fda approvals ↗

Apr 1, 2026approval150d agoBREXPIPRAZOLE — FDA approvalBREXPIPRAZOLE

Sponsor: AMNEAL. Form: TABLET. Route: ORAL

full page →BREXPIPRAZOLE →fda approvals ↗

Apr 1, 2026approval150d agoBREXPIPRAZOLE — FDA approvalBREXPIPRAZOLE

Sponsor: AMNEAL. Form: TABLET. Route: ORAL

full page →BREXPIPRAZOLE →fda approvals ↗

Apr 1, 2026approval150d agoBREXPIPRAZOLE — FDA approvalBREXPIPRAZOLE

Sponsor: AMNEAL. Form: TABLET. Route: ORAL

full page →BREXPIPRAZOLE →fda approvals ↗

Apr 1, 2026approval150d agoBREXPIPRAZOLE — FDA approvalBREXPIPRAZOLE

Sponsor: AMNEAL. Form: TABLET. Route: ORAL

full page →BREXPIPRAZOLE →fda approvals ↗

Apr 1, 2026approval150d agoFOUNDAYO (ORFORGLIPRON CALCIUM) — FDA approvalorforglipron calcium

Sponsor: ELI LILLY AND CO. Form: TABLET. Route: ORAL

full page →orforglipron calcium →fda approvals ↗

Apr 1, 2026approval150d agoPROCHLORPERAZINE EDISYLATE — FDA approvalPROCHLORPERAZINE EDISYLATE

Sponsor: SOMERSET THERAPS LLC. Form: INJECTABLE. Route: INJECTION

full page →PROCHLORPERAZINE EDISYLATE →fda approvals ↗

Apr 2, 2026approval149d agoNINTEDANIB ESYLATE — FDA approvalBoehringer Ingelheim Corp

Sponsor: DR REDDYS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Apr 2, 2026approval149d agoACETAZOLAMIDE — FDA approvalACETAZOLAMIDE

Sponsor: HERITAGE PHARMA. Form: TABLET. Route: ORAL

full page →ACETAZOLAMIDE →fda approvals ↗

Apr 2, 2026approval149d agoNINTEDANIB ESYLATE — FDA approvalOfev

Sponsor: SANDOZ. Form: CAPSULE. Route: ORAL

full page →Ofev →fda approvals ↗

Apr 2, 2026approval149d agoEYLEA HD (AFLIBERCEPT) — FDA approvalEYLEA HD

Sponsor: REGENERON PHARMACEUTICALS. Form: INJECTABLE. Route: INJECTION

full page →EYLEA HD →fda approvals ↗

Apr 2, 2026approval149d agoGABAPENTIN — FDA approvalAlmatica Pharma LLC

Sponsor: ALKEM LABS LTD. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Apr 2, 2026approval149d agoPALIPERIDONE — FDA approvalEskayef Pharmaceuticals Ltd

Sponsor: ACTAVIS LABS FL INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗

Apr 2, 2026approval149d agoNINTEDANIB ESYLATE — FDA approvalOfev

Sponsor: CIPLA. Form: CAPSULE. Route: ORAL

full page →Ofev →fda approvals ↗

Apr 2, 2026approval149d agoGABAPENTIN — FDA approvalGABAPENTIN

Sponsor: STRIDES PHARMA. Form: CAPSULE. Route: ORAL

full page →GABAPENTIN →fda approvals ↗

Apr 2, 2026approval149d agoNINTEDANIB ESYLATE — FDA approvalOfev

Sponsor: DEXCEL. Form: CAPSULE. Route: ORAL

full page →Ofev →fda approvals ↗

← prev

page 1 of 5

Week of Mar 30, 2026